scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019814579 |
P356 | DOI | 10.1136/ANNRHEUMDIS-2013-204223 |
P8608 | Fatcat ID | release_mn27ubbqqbayneqn3uvgicpwm4 |
P932 | PMC publication ID | 3888623 |
P698 | PubMed publication ID | 24095940 |
P5875 | ResearchGate publication ID | 257462864 |
P50 | author | Paul Emery | Q19859634 |
Helga Radner | Q88548670 | ||
Emilio Martin-Mola | Q88996849 | ||
Kevin L Winthrop | Q90243645 | ||
Najia Hajjaj-Hassouni | Q39410823 | ||
Iain McInnes | Q41687181 | ||
Maya Hema Buch | Q44940582 | ||
Jonathan Kay | Q45733563 | ||
Jacqueline Detert | Q47262425 | ||
Alejandro Balsa | Q57028851 | ||
Martin Soubrier | Q58884902 | ||
Maxime Dougados | Q63136268 | ||
Josef S Smolen | Q66753681 | ||
P2093 | author name string | Yeong-Wook Song | |
Shue-Fen Luo | |||
Masayoshi Harigai | |||
Peter Balint | |||
Carlo Maurizio Montecucco | |||
Gustavo Casado | |||
Jacqueline Detert | |||
Gabriel Maciel | |||
Bassel El-Zorkany | |||
Reka Kurucz | |||
Anna Antunez | |||
Harald Erwin Vonkeman | |||
P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis | Q28168900 | ||
An audit of influenza and pneumococcal vaccination in rheumatology outpatients | Q33289919 | ||
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
Why do people with rheumatoid arthritis still die prematurely? | Q33697879 | ||
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers | Q33706159 | ||
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register | Q73574433 | ||
Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem | Q79918765 | ||
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33740111 | ||
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
The mortality of rheumatoid arthritis | Q34338843 | ||
Interaction between smoking and HLA-DRB1*04 gene is associated with a high cardiovascular risk in Brazilian Amazon patients with rheumatoid arthritis | Q34388610 | ||
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. | Q34986307 | ||
Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial | Q35980636 | ||
Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites: the atherosclerosis risk in communities study | Q36077038 | ||
No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population | Q36291405 | ||
Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis | Q36464352 | ||
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality | Q36789999 | ||
Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis | Q36907729 | ||
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research | Q37342445 | ||
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search | Q37710906 | ||
High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China | Q37728704 | ||
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases | Q37816066 | ||
EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis | Q37950992 | ||
Co-morbidities in established rheumatoid arthritis. | Q37964309 | ||
Impact of hepatitis B vaccination among children in Guangdong Province, China | Q38026237 | ||
Malignancy as a comorbidity in rheumatic diseases | Q38029322 | ||
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment | Q38063474 | ||
Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection. | Q38856012 | ||
Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients. | Q38991185 | ||
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. | Q39542487 | ||
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses | Q43636113 | ||
Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry | Q43736535 | ||
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study | Q45792532 | ||
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. | Q51211966 | ||
Development of a disease activity score based on judgment in clinical practice by rheumatologists. | Q52399756 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatoid arthritis | Q187255 |
comorbidity | Q1414874 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 62-68 | |
P577 | publication date | 2013-10-04 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). | |
P478 | volume | 73 |
Q37696434 | "You Obviously Just Have to Put on a Brave Face": A Qualitative Study of the Experiences and Coping Styles of Men With Rheumatoid Arthritis |
Q40035636 | 'The lesser of two evils…' - views of persons with rheumatoid arthritis on medication adherence: a qualitative study. |
Q36963507 | A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis |
Q58794686 | An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome‑protamine-DNA-siRNA complex with cell permeable peptides |
Q64060558 | An integrative transcriptome analysis framework for drug efficacy and similarity reveals drug-specific signatures of anti-TNF treatment in a mouse model of inflammatory polyarthritis |
Q54936252 | Association between Rheumatoid Arthritis and Respiratory Allergic Diseases in Korean Adults: A Propensity Score Matched Case-Control Study. |
Q40216184 | Association of Somatic Comorbidities and Comorbid Depression With Mortality in Patients With Rheumatoid Arthritis: A 14-Year Prospective Cohort Study |
Q30234766 | Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma |
Q90153398 | Attitudes towards Oral Health in Patients with Rheumatoid Arthritis: A Qualitative Study Nested within a Randomized Controlled Trial |
Q58621582 | Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O |
Q26864064 | Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators |
Q92737108 | Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs |
Q90602641 | COVID-19 infection and rheumatoid arthritis: Faraway, so close! |
Q91776881 | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions |
Q35891702 | Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis |
Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
Q90629334 | Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study |
Q90673384 | Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study |
Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
Q97517449 | Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review |
Q35224179 | Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years |
Q45796102 | Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis |
Q47320087 | Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa. |
Q91909930 | Chronic obstructive pulmonary disease and rheumatic diseases: A systematic review on a neglected comorbidity |
Q38262835 | Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment |
Q91750406 | Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis |
Q52624368 | Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment. |
Q44807577 | Clinical guidelines: Addressing comorbidities in systemic inflammatory disorders |
Q38615462 | Co-morbidity index in rheumatoid arthritis: time to think |
Q40354684 | Coexistent malignant conditions in rheumatoid arthritis - A population-based cross-sectional study |
Q60912319 | Common mechanisms and holistic care in atherosclerosis and osteoporosis |
Q55497929 | Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated aetiopathogenesis. |
Q39829013 | Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis |
Q42680293 | Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). |
Q45826937 | Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis. |
Q92570415 | Comorbidities in inflammatory bowel disease: a call for action |
Q41588352 | Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis. |
Q58779794 | Comorbidities in rheumatic arthritis |
Q33579891 | Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey |
Q36471067 | Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis |
Q38990549 | Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis. |
Q36220832 | Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study. |
Q39146167 | Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients. |
Q26765282 | Costs associated with rheumatoid arthritis in Italy: past, present, and future |
Q61812081 | Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time |
Q35470652 | Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. |
Q48056228 | Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study. |
Q92060736 | Determining Rheumatology Patient Interest in a Group Strength Training Program - Results of an Exercise Survey |
Q36593810 | Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process |
Q35985497 | Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan |
Q54984291 | Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study. |
Q57163056 | Disease and management beliefs of elderly patients with rheumatoid arthritis and comorbidity: a qualitative study |
Q91972505 | Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis |
Q91663787 | Dose-response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case-control study |
Q64068266 | Drug-related problems in patients with rheumatoid arthritis |
Q39027986 | Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients. |
Q47552171 | Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study |
Q92176543 | Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib |
Q40687578 | Efficacy of a Rheumatoid Arthritis-Specific Smoking Cessation Program: A Randomized Controlled Pilot Trial |
Q45875046 | Engineering Specificity and Function of Therapeutic Regulatory T Cells. |
Q60300869 | Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients |
Q52602682 | Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD). |
Q33800700 | Evaluation of Vitamin D Status in Rheumatoid Arthritis and Its Association with Disease Activity across 15 Countries: "The COMORA Study". |
Q61809484 | Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study |
Q35654020 | Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial |
Q47944378 | Examining the Relationship Between Pain Catastrophizing and Suicide Risk in Patients with Rheumatic Disease: the Mediating Role of Depression, Perceived Social Support, and Perceived Burdensomeness |
Q31153194 | Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. |
Q91584436 | Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus |
Q57299625 | Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project |
Q88455843 | Frequency and Predictors of Communication About High Blood Pressure in Rheumatoid Arthritis Visits |
Q31149663 | Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA. |
Q55000662 | Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease. |
Q30238991 | Healthcare burden of depression in adults with arthritis |
Q40212689 | High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. |
Q47625199 | High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data |
Q92278043 | Household air pollution and arthritis in low-and middle-income countries: Cross-sectional evidence from the World Health Organization's study on Global Ageing and Adult Health |
Q64247492 | IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study |
Q36005210 | Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). |
Q38844078 | Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis. |
Q40195611 | In rheumatoid arthritis, country of residence has an important influence on fatigue: results from the multinational COMORA study |
Q39371950 | In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study |
Q46337002 | Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis |
Q64231412 | Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study |
Q92703340 | Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review |
Q41507083 | Indirect costs associated with early exit from work attributable to rheumatic diseases |
Q35813953 | Inhibition on JAK-STAT3 Signaling Transduction Cascade Is Taken by Bioactive Peptide Alpha-S2 Casein Protein from Goat Ethawah Breed Milk |
Q55279319 | Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression? |
Q42134953 | Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORA. |
Q38554197 | Lipid and Metabolic Changes in Rheumatoid Arthritis. |
Q58567872 | Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment |
Q30888876 | Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort |
Q39371943 | Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study |
Q99202798 | Managing rheumatoid arthritis during COVID-19 |
Q55018553 | Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis. |
Q36633607 | Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B. |
Q37243485 | Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C. |
Q43199986 | Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model. |
Q35393861 | Mining disease risk patterns from nationwide clinical databases for the assessment of early rheumatoid arthritis risk |
Q38908843 | Modeling quality of life in patients with rheumatic diseases: the role of pain catastrophizing, fear-avoidance beliefs, physical disability, and depression |
Q90415257 | Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients |
Q28070338 | Multimorbidity in rheumatic conditions |
Q47692825 | Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis |
Q64271473 | New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib |
Q64951770 | New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study. |
Q38634276 | Novel approaches to biological therapy for psoriatic arthritis |
Q39371685 | Novel treatment strategies in rheumatoid arthritis. |
Q35633961 | Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based survey |
Q37021279 | Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making |
Q41026313 | Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study |
Q28603520 | Patient Perspectives on Sharing Anonymized Personal Health Data Using a Digital System for Dynamic Consent and Research Feedback: A Qualitative Study |
Q60928282 | Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults |
Q37242610 | Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea |
Q50047407 | Perioperative Inpatient Use of Selective Serotonin Reuptake Inhibitors Is Associated With a Reduced Risk of THA and TKA Revision. |
Q89996621 | Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis |
Q47674117 | Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer |
Q38777496 | Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative |
Q59813359 | Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry |
Q41168364 | Power of national economy, disease control and employment status in patients with RA-an analytical multi-site ecological study |
Q64996337 | Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study. |
Q94591396 | Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study |
Q97532363 | Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients |
Q37206056 | Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. |
Q40307261 | Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA). |
Q40405924 | Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study |
Q38691780 | Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis |
Q59793023 | Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study |
Q50002598 | Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg |
Q40830395 | Prevention of HBV reactivation in patients treated with biologic agents. |
Q39082330 | Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada. |
Q90454106 | Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study |
Q26744032 | Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? |
Q90608529 | Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations |
Q60954470 | Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study |
Q64259679 | Response to: "A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial" |
Q90117853 | Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort |
Q52578723 | Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study. |
Q47552951 | Rheumatoid arthritis: A single-center Egyptian experience. |
Q35896998 | Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001-2011. |
Q90415221 | Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report |
Q55341968 | Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan. |
Q58735831 | Sarilumab: patient-reported outcomes in rheumatoid arthritis |
Q91641942 | Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients |
Q39665336 | Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. |
Q40807740 | Serious infections in patients with rheumatoid arthritis |
Q35792901 | Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial |
Q35970365 | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State |
Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
Q47671088 | Sex, Symptom Severity, and Quality of Life in Rheumatology |
Q52622829 | Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results. |
Q90133923 | Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls |
Q47110507 | Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study |
Q39242725 | Tackling comorbidity associated with rheumatic diseases in standard practice |
Q60959818 | Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? |
Q58803289 | The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial |
Q89860622 | The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review |
Q47101018 | The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis |
Q36187856 | The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank |
Q61797300 | The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors |
Q90434053 | The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis |
Q90494559 | The association between Bell's palsy and rheumatoid arthritis: A longitudinal study |
Q48075422 | The burden of disease in rheumatoid arthritis |
Q36000249 | The challenging interplay between rheumatoid arthritis, ageing and comorbidities |
Q31151686 | The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights |
Q39638950 | The correlations of socioeconomic status, disease activity, quality of life, and depression/anxiety in Chinese patients with rheumatoid arthritis |
Q38671481 | The dynamic evolution of rheumatology in Korea |
Q36761926 | The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis |
Q64984148 | The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values. |
Q36895220 | The influence of lifestyle habits on quality of life in patients with established rheumatoid arthritis-A constant balancing between ideality and reality |
Q88795124 | The influence of thyroid diseases, diabetes mellitus, primary hyperparathyroidism, vitamin B12 deficiency and other comorbid autoimmune diseases on treatment outcome in patients with rheumatoid arthritis: An exploratory cohort study |
Q92308481 | The physiological significance of the circadian dynamics of the HPA axis: Interplay between circadian rhythms, allostasis and stress resilience |
Q57972405 | The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank |
Q40125487 | The psychosocial status of the family members of rheumatoid arthritis patients in Korea |
Q89830820 | The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study |
Q52654900 | The role of lymphotoxin-α in rheumatoid arthritis. |
Q47097488 | Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study |
Q54965764 | Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis. |
Q40492165 | Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting |
Q36300479 | Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations |
Q57169964 | Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis |
Q93061961 | Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe |
Q55405093 | Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. |
Q34394394 | Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting. |
Q35045933 | Utility of different cardiovascular disease prediction models in rheumatoid arthritis |
Q48046623 | Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge |
Q28074148 | What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? |
Q46745289 | When treating rheumatoid arthritis be vigilant for influenza (& pneumonia): Don't ignore, don't neglect |
Q40603508 | Which Factors Influence Self-Efficacy in Patients with Chronic Inflammatory Polyarthritis? |
Q52839369 | [Choosing wisely recommendations in rheumatology : One year after their first publication]. |
Q87510837 | [Collation of comorbidities: core competence of internist rheumatologists] |
Q90258576 | [Depressive symptoms in early rheumatoid arthritis : Within the rheumatism network ADAPTHERA] |
Q52876178 | [Gender-specific differences in comorbidities of rheumatoid arthritis]. |
Q90235204 | [Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population] |
Q52878034 | [Safety of antirheumatic drug treatment in the elderly]. |
Q52850236 | [Standardized outcome parameters]. |
Q87387286 | [Treatment of cardiovascular risk factors] |
Q87320426 | [Which kind of structures and facilities are needed for the care of elderly patients with rheumatic diseases?] |
Search more.